Organovo Will 3D Print a Liver in 2014

Like this? Share it.TwitterFacebookGoogle+ReddittumblrbufferEmail

Organovo (NYSE: ONVO) is pioneering the field of bioprinting, or 3D printing living tissue. To date, the company has demonstrated the ability to 3D print living tissue in a lab environment for the purposes of testing new drug therapies.

Now it looks like the company will achieve the holy grail of bioprinting next year: 3D printing a human liver.

Read: Bioprinting is a Multi-Billion Dollar Pharma Opportunity for 3D Printing

The technical challenge to 3D printing a full organ is that an organ needs a vascular system for blood flow and vitality. Organovo now believes it has the capability to embed a vascular system in a 3D printed liver.

“We have achieved thicknesses of greater than 500 microns, and have maintained liver tissue in a fully functional state with native phenotypic behavior for at least 40 days,” said Mike Renard, Organovo’s executive vice president of commercial operations in an interview with ComputerWorld.

Keith Murphy Organovo Keynote

(Pictured above: Organovo CEO Keith Murphy presents his roadmap at Inside 3D Printing San Jose 2013)

We probably won’t see a 3D printed organ implanted in a human patient in 2014, but just producing living tissue at the scale of a liver is groundbreaking.


Like this? Share it.TwitterFacebookGoogle+ReddittumblrbufferEmail

One Response to Organovo Will 3D Print a Liver in 2014

  1. […] pioneer Organovo looks to 3D print a full-scale human liver in 2014, achieving the holy grail of […]

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>